Copper-64

Copper-64

3D space-filling model of Copper-ATSM

Copper-64 is a radioisotope of copper with a half-life of 12.7 hours. It is used in nuclear medicine for positron emission tomography (PET) imaging and radiotherapy.

Properties

Copper-64 decays by beta decay and positron emission, making it versatile for both diagnostic and therapeutic purposes. It emits beta particles and positrons, which can be detected by PET scanners, providing high-resolution images of biological processes in the body.

Production

Copper-64 is produced in cyclotrons by bombarding nickel-64 with protons. The reaction involves the transformation of nickel-64 into copper-64 through a nuclear reaction. This process requires precise control of the energy and intensity of the proton beam to optimize yield and purity.

Applications

Copper-64 is used in the development of radiopharmaceuticals for imaging and therapy. One of the most studied compounds is Copper-ATSM, which is used for imaging hypoxia in tumors. Hypoxic regions in tumors are often resistant to conventional therapies, making them important targets for imaging and treatment.

Diagnostic Imaging

In diagnostic imaging, copper-64 is used in PET scans to visualize metabolic activity in tissues. It is particularly useful in oncology for detecting and monitoring cancer due to its ability to highlight areas of increased metabolic activity, which are often indicative of tumor growth.

Therapeutic Uses

Copper-64 can also be used in targeted radionuclide therapy. Its emission of beta particles allows it to deliver therapeutic doses of radiation to specific sites, such as cancerous tissues, while minimizing damage to surrounding healthy tissues.

Safety and Handling

As with all radioactive materials, copper-64 must be handled with care to minimize exposure to radiation. Proper radiation safety protocols must be followed, including the use of shielding, personal protective equipment, and radiation monitoring devices.

Related pages

• Radioisotope
• Positron emission tomography
• Radiopharmaceutical
• Nuclear medicine
• Copper